[1]Weiss RH.Metabolomics and metabolic reprogramming in kidney cancer[J].Seminars in Nephrology,2018(38):175-182.
[2]Allison SJ.Kidney cancer:Targeting metabolism in RCC[J].Nature Reviews Nephrology,2017(13):320.
[3]Wuttke M,Li Y,Li M,et al.A catalog of genetic loci associated with kidney function from analyses of a million individuals[J].Nature Genetics,2019(51):957-972.
[4]Castillo RP,Santoscoy JF,Pisani L,et al.Imaging of unusual renal tumors[J].Current Urology Reports,2019(20):5.
[5]Ma R,Zhu X,Yan B.SCARB1 rs5888 gene polymorphisms in coronary heart disease:A systematic review and a Meta-analysis[J].Gene,2018(678):280-287.
[6]Liu Y,Nan F,Lu K,et al.Identification of key genes in endometrioid endometrial adenocarcinoma via TCGA database[J].Cancer Biomarkers:Section A of Disease Markers,2017(21):11-21.
[7]Shingarev R,Jaimes EA.Renal cell carcinoma:New insights and challenges for a clinician scientist[J].American Journal of Physiology Renal Physiology,2017(313):F145-F154.
[8]Kuusk T,Grivas N,Bruijn R,et al.The current management of renal cell carcinoma[J].Minerva Medica,2017(108):357-369.
[9]Maranchie JK.Basic/translational science survey:Kidney cancer[J].Urologic Oncology,2017(35):160.
[10]Otto AM.Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism[J].Cancer & Metabolism,2016(4):5.
[11]Munir R,Lises J,Swinnen JV,et al.Lipid metabolism in cancer cells under metabolic stress[J].British Journal of Cancer,2019(120):1090-1098.
[12]Barova A,Altomare D,Creek KE,et al.Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma[J].PloS One,2017(12):e0172632.
[13]Wilson KM,Cho E.Obesity and kidney cancer[J].Recent Results in Cancer Research,2016(208):81-93.
[14]Yang X,Sethi A,Yanek LR,et al.SCARB1 gene variants are associated with the phenotype of combined high high-density lipoprotein cholesterol and high lipoprotein (a)[J].Circulation Cardiovascular Genetics,2016(9):408-418.
[15]Horiguchi A,Aanao T.Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma[J].The Journal of Urology,2008(180):1137-1140.
[16]Von Roemeling CA,Marlow LA,Wei JJ,et al.Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma[J].Clinical Cancer Research,2013(19):2368-2380.